Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Christopher Viehbacher
Pharma
Sanofi was 'Party A' in Reata bidding war: Bloomberg
The tale of Biogen’s Reata courtship is being laid bare.
Fraiser Kansteiner
Aug 16, 2023 11:09am
How Biogen courted Reata for $7.3B—and outbid a competitor
Aug 15, 2023 10:05am
'The Top Line': Biogen's new CEO, plus this week's headlines
Dec 2, 2022 8:34am
Investors divided on Biogen's hire of new CEO Viehbacher
Nov 11, 2022 10:30am
Biogen taps former Sanofi chief Viehbacher as CEO
Nov 10, 2022 8:49am
